BTG3 and hypoparathyroidism: Two participants in the 100 μg Na-GST-1/Alhydrogel group did not receive the third dose: one participant developed an elevated ANA following the second injection and the other participant did not receive the third and final injection due to the discovery of previously undisclosed past history of an exclusionary health condition (hypoparathyroidism).